| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/03/2009 | US20090220587 Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| 09/03/2009 | US20090220536 HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 |
| 09/03/2009 | US20090220534 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes |
| 09/03/2009 | US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220486 Antibodies and uses thereof |
| 09/03/2009 | US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/03/2009 | US20090220435 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 09/03/2009 | US20090220432 Imaging agents and methods of using same for detecting multidrug resistance in cancer |
| 09/03/2009 | US20090220430 Fluorescent Imaging Agents |
| 09/03/2009 | CA2716622A1 Glycopeptides and methods of making and using them |
| 09/02/2009 | EP2096118A1 Antifungal peptides |
| 09/02/2009 | EP1620056B1 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/02/2009 | EP1601766B1 Peptides capable of inhibiting dimerisation of c-Jun |
| 09/02/2009 | EP1557466B1 Tumor antigen protein and utilization thereof |
| 09/02/2009 | EP1495045B1 Cytoplasmic transduction peptides and uses thereof |
| 09/02/2009 | EP1456229B1 Method for preparing echinocandin derivatives |
| 09/02/2009 | EP1320595B1 Production process of surfactin |
| 09/02/2009 | CN101519438A Cyclic peptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519437A Cyclic heptapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519436A Cyclic octapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519435A Cyclic nonapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519434A Extraction process of nosiheptide raw powder |
| 09/02/2009 | CN101519426A Lactalbumin polypeptide with antioxidation activity and preparation method thereof |
| 09/02/2009 | CN100534535C Improved linkers for pharmaceutical compounds |
| 09/01/2009 | US7584059 Inhibition of immune complex formation |
| 09/01/2009 | US7582728 Microwave-assisted peptide synthesis |
| 09/01/2009 | US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same |
| 09/01/2009 | US7582604 Template-fixed peptidomimetics with antibacterial activity |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582461 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity |
| 09/01/2009 | US7582441 Diagnosing lung cancer by differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells; determining a higher level of Na-K ATPase beta3 protein in a sample from the subject's lung; amino acid sequence; determining the extent of binding of antibody to Na-K ATPase |
| 09/01/2009 | US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009103898A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/27/2009 | WO2009103828A1 Improved analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit |
| 08/27/2009 | WO2009103127A1 Therapeutic peptides |
| 08/27/2009 | WO2009103105A2 Mimotope |
| 08/27/2009 | WO2009083663A3 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 08/27/2009 | WO2009041830A9 Cell-permeabilising peptides and polypeptides for microbial cells |
| 08/27/2009 | US20090215987 Peptide amidation process |
| 08/27/2009 | US20090215983 Compounds and methods for inhibiting hepatitis C virus replication |
| 08/27/2009 | US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 08/27/2009 | US20090215878 Treatment of chronic pain with zinc finger proteins |
| 08/27/2009 | US20090215701 Enhancement of Iron Chelation Therapy |
| 08/27/2009 | US20090215700 amino acid substitutes provide blood stability, solubility, pharmacokinetics, supression of cancer metastasis; gelation tendency is reduced; gonadotropic hormone secretion is suppressed; Ac-D-Tyr-Hyp-Asn-Thr-Cha-Gly-Ala(cPr)-Arg(Me)-Trp-NH2 |
| 08/27/2009 | US20090215699 Pharmaceutically Active Antiviral Peptides |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215689 Fgf2-binding peptides and uses thereof |
| 08/27/2009 | US20090215683 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 08/27/2009 | US20090215677 Polymyxin derivatives and uses thereof |
| 08/27/2009 | US20090215675 Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| 08/27/2009 | US20090215666 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 08/27/2009 | US20090215665 Compositions and methods for promoting wound healing and tissue regeneration |
| 08/27/2009 | US20090215172 Methods and Compositions Related to Cyclic Peptide Synthesis |
| 08/27/2009 | US20090215169 Method for regulating protein function in cells using synthetic small molecules |
| 08/27/2009 | US20090215113 Methods for purifying pertussis toxin and peptides useful therefor |
| 08/27/2009 | US20090215101 HCV Protease substrates |
| 08/27/2009 | US20090215025 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 08/27/2009 | US20090214653 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 08/27/2009 | US20090214583 Epitope-enhancement of a human cd4 hiv epitope |
| 08/27/2009 | US20090214582 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
| 08/27/2009 | US20090214581 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 08/27/2009 | US20090214571 Colon cancer related gene tom34 |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214498 Antimicrobial peptides and bacterial strains that produce them |
| 08/27/2009 | US20090214489 Peptides and compounds that bind to a receptor |
| 08/27/2009 | US20090214480 Novel cancer antigen peptide and the use thereof |
| 08/27/2009 | US20090214467 Methods of protecting against apoptosis using lipopeptides |
| 08/27/2009 | US20090214436 Dichromic fluorescent compounds |
| 08/27/2009 | US20090214430 Polypeptide specifically bound to phosphatidylserine and the use thereof |
| 08/27/2009 | US20090214429 Methods and compositions related to targeting tumors and wounds |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | CA2716007A1 Mimotope |
| 08/27/2009 | CA2714853A1 Selective poly-n-substituted glycine antibiotics |
| 08/27/2009 | CA2709907A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/26/2009 | EP2093570A1 Modulating the interaction between HGF beta chain and c-met |
| 08/26/2009 | EP2093287A1 Igg-binding peptide |
| 08/26/2009 | EP2093234A1 Oligopeptides for use as taste modulators |
| 08/26/2009 | EP2092937A2 Immunotherapeutic and immunoprophylactic reagents |
| 08/26/2009 | EP2091965A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 08/26/2009 | EP2091960A2 Peptide vaccine for influenza virus |
| 08/26/2009 | EP2091959A1 Improved peptide composition |
| 08/26/2009 | EP1625153B1 Acylated lysobactin-type nonadepsipeptides |
| 08/26/2009 | EP1624885A4 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 08/26/2009 | EP1585537A4 1-desamino-8-d-arginyl vasopressin analogs |
| 08/26/2009 | EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1451207B1 Labeling reagent and methods of use |
| 08/26/2009 | EP1379698B1 Mobility-modified nucleobase polymers and methods of using same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | EP0774120B1 Peptides marked with metal chelates |
| 08/26/2009 | CN101516903A Process for the manufacture of peptides |
| 08/26/2009 | CN101514225A Self-polymerization polypeptide and preparation method and application thereof |
| 08/25/2009 | US7579436 Amino acid sequences for use in measuring concentration of sulfur and ammonia compounds |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579434 Peptide having ability to activate cancer-related gene |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 08/25/2009 | US7579321 Incotinence therapy controlling dosage |